Kenya faces a growing challenge of substandard and counterfeit medicines despite having a robust pharmaceutical industry, including guidelines for regulation sector players.
Substandard medicines are those that are licensed but do not meet quality specifications. In contrast, counterfeits are deliberately and fraudulently mislabelled as to their identity and/or source.
